The store will not work correctly when cookies are disabled.
(E)-8-(2-(1H-Benzo[d]imidazol-2-yl)hydrazono)-5,6,7,8-tetrahydroquinoline
ID: ALA4791490
PubChem CID: 162670961
Max Phase: Preclinical
Molecular Formula: C16H15N5
Molecular Weight: 277.33
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1cnc2c(c1)CCC/C2=N\Nc1nc2ccccc2[nH]1
Standard InChI: InChI=1S/C16H15N5/c1-2-8-13-12(7-1)18-16(19-13)21-20-14-9-3-5-11-6-4-10-17-15(11)14/h1-2,4,6-8,10H,3,5,9H2,(H2,18,19,21)/b20-14+
Standard InChI Key: RAKVRAHSECQXBX-XSFVSMFZSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
10.6386 -10.9046 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9295 -11.3132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2204 -10.9046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2204 -10.0874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9295 -9.6788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9295 -8.8616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6386 -8.4530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3435 -8.8616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3435 -9.6788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6386 -10.0874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0526 -10.0874 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7617 -9.6788 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4708 -10.0874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5548 -10.9020 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3532 -11.0727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7618 -10.3636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2140 -9.7572 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5790 -10.3636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9876 -11.0727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5790 -11.7818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7618 -11.7818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
1 10 1 0
5 10 2 0
11 12 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
13 17 2 0
18 19 1 0
19 20 2 0
20 21 1 0
15 21 2 0
16 18 2 0
12 13 1 0
9 11 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 277.33 | Molecular Weight (Monoisotopic): 277.1327 | AlogP: 3.11 | #Rotatable Bonds: 2 |
Polar Surface Area: 65.96 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.25 | CX Basic pKa: 5.45 | CX LogP: 3.53 | CX LogD: 3.36 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.71 | Np Likeness Score: -1.05 |
References
1. Chen G,Niu C,Yi J,Sun L,Cao H,Fang Y,Jin T,Li Y,Lou C,Kang J,Wei W,Zhu J. (2019) Novel Triapine Derivative Induces Copper-Dependent Cell Death in Hematopoietic Cancers., 62 (6.0): [PMID:30835473] [10.1021/acs.jmedchem.8b01996] |